This systematic review aimed to estimate the prevalence of MMR deficiency and confirmed LS in young patients diagnosed with CRC before the age of 50 and examine immunohistochemistry mismatch repair testing patterns and associated molecular findings (BRAF mutations, MLH1 promoter hypermethylation, somatic MMR gene alterations). The gene discussed is MRC1; the disease is mismatch repair cancer syndrome 1.